Pancreatic Cancer in the USA: Persistence of Undertreatment and Poor Outcome

Despite decades of research, consensus on optimal treatment for pancreatic cancer has not been reached and survival remains bleak. This study aimed to evaluate predictors of treatment and survival among patients treated in community settings. A sample of pancreatic cancer patients who were diagnosed in 2009 and reported to the National Cancer Institute’s Surveillance Epidemiology and End Results (SEER) program (n = 977) was included. Logistic...